We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Events

09 Apr 2024 - 12 Apr 2024
15 Apr 2024 - 17 Apr 2024
23 Apr 2024 - 26 Apr 2024

Ultrasensitive Screening Platform Detects Pathogenic Bacteria

By LabMedica International staff writers
Posted on 05 Nov 2018
Print article
Image: Researchers have developed the first diagnostic platform that can simultaneously screen for all known human pathogenic bacteria, as well as markers for virulence and antibiotic resistance (Photo courtesy of Columbia University).
Image: Researchers have developed the first diagnostic platform that can simultaneously screen for all known human pathogenic bacteria, as well as markers for virulence and antibiotic resistance (Photo courtesy of Columbia University).
A diagnostic platform has been developed that significantly increases the sensitivity of high-throughput sequencing for detection and characterization of bacteria, virulence determinants, and antimicrobial resistance (AMR) genes.

Investigators at Columbia University (New York, NY, USA) recently described the BacCapSeq (bacterial capture sequencing) system, which was designed to complement the earlier VirCapSeq test that screens for all known human viral infections.

The BacCapSeq system is based on a probe set comprising 4.2 million oligonucleotides extracted from the Pathosystems Resource Integration Center (PATRIC) database, the Comprehensive Antibiotic Resistance Database (CARD), and the Virulence Factor Database (VFDB), representing 307 bacterial species that include all known human-pathogenic species, known antimicrobial resistance genes, and known virulence factors, respectively. These genetic probes are introduced alongside material taken from the sample being tested. A magnetic process isolates segments from the sample that match the probe, and these segments are then analyzed using high-throughput sequencing.

The use of the 70-hour BacCapSeq test resulted in an up to 1,000-fold increase in bacterial reads from blood samples and lowered the limit of detection by one to two orders of magnitude compared to conventional unbiased high-throughput sequencing,
At this level of sensitivity, the test detected not only the presence of AMR genes but also biomarkers for AMR that included both constitutive and differentially expressed transcripts.

"Microbiological intelligence must be an integral component of precision medicine," said senior author Dr. W. Ian Lipkin, professor of epidemiology at Columbia University. "Accurate, early differential diagnosis of infectious diseases and knowledge of drug sensitivity profiles will reduce mortality, morbidity, and health care costs."

The BacCapSeq diagnostic platform was described in the October 23, 2018, online edition of the journal mBio.

Related Links:
Columbia University

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
HLX
Complement 3 (C3) Test
GPP-100 C3 Kit
New
Gold Member
Magnetic Bead Separation Modules
MAG and HEATMAG

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The medical office procedure detects the key biomarker in Parkinson’s and related neurodegenerative diseases (Photo courtesy of BIDMC)

Simple Skin Biopsy Test Detects Parkinson’s and Related Neurodegenerative Diseases

Parkinson's disease and a group of related neurodegenerative disorders known as synucleinopathies impact millions globally. These conditions, including Parkinson’s disease (PD), dementia with Lewy bodies... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.